• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

国际性多中心研究方案在大流行期间进行肝脏移植:四方平衡的案例。

An international multicenter study of protocols for liver transplantation during a pandemic: A case for quadripartite equipoise.

机构信息

National University Hospital, Singapore.

Architectural Association School of Architecture, London, United Kingdom.

出版信息

J Hepatol. 2020 Oct;73(4):873-881. doi: 10.1016/j.jhep.2020.05.023. Epub 2020 May 23.

DOI:10.1016/j.jhep.2020.05.023
PMID:32454041
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7245234/
Abstract

BACKGROUND & AIMS: The outbreak of COVID-19 has vastly increased the operational burden on healthcare systems worldwide. For patients with end-stage liver failure, liver transplantation is the only option. However, the strain on intensive care facilities caused by the pandemic is a major concern. There is an urgent need for ethical frameworks to balance the need for liver transplantation against the availability of national resources.

METHODS

We performed an international multicenter study of transplant centers to understand the evolution of policies for transplant prioritization in response to the pandemic in March 2020. To describe the ethical tension arising in this setting, we propose a novel ethical framework, the quadripartite equipoise (QE) score, that is applicable to liver transplantation in the context of limited national resources.

RESULTS

Seventeen large- and medium-sized liver transplant centers from 12 countries across 4 continents participated. Ten centers opted to limit transplant activity in response to the pandemic, favoring a "sickest-first" approach. Conversely, some larger centers opted to continue routine transplant activity in order to balance waiting list mortality. To model these and other ethical tensions, we computed a QE score using 4 factors - recipient outcome, donor/graft safety, waiting list mortality and healthcare resources - for 7 countries. The fluctuation of the QE score over time accurately reflects the dynamic changes in the ethical tensions surrounding transplant activity in a pandemic.

CONCLUSIONS

This four-dimensional model of quadripartite equipoise addresses the ethical tensions in the current pandemic. It serves as a universally applicable framework to guide regulation of transplant activity in response to the increasing burden on healthcare systems.

LAY SUMMARY

There is an urgent need for ethical frameworks to balance the need for liver transplantation against the availability of national resources during the COVID-19 pandemic. We describe a four-dimensional model of quadripartite equipoise that models these ethical tensions and can guide the regulation of transplant activity in response to the increasing burden on healthcare systems.

摘要

背景与目的

COVID-19 的爆发使全球医疗系统的运营负担大大增加。对于终末期肝功能衰竭的患者来说,肝移植是唯一的选择。然而,大流行对重症监护设施造成的压力是一个主要的关注点。迫切需要制定伦理框架,在肝移植的需求与国家资源的可获得性之间取得平衡。

方法

我们对移植中心进行了一项国际多中心研究,以了解 2020 年 3 月为应对大流行而对移植优先次序进行政策调整的演变。为了描述在这种情况下出现的伦理紧张局势,我们提出了一种新的伦理框架,即四分平衡(QE)评分,适用于在有限的国家资源背景下进行肝移植。

结果

来自四大洲 12 个国家的 17 个大型和中型肝移植中心参与了这项研究。十个中心选择限制移植活动以应对大流行,倾向于采用“病情最严重者优先”的方法。相反,一些较大的中心选择继续常规的移植活动,以平衡等待名单上的死亡率。为了模拟这些和其他伦理紧张局势,我们使用 4 个因素(受者结局、供体/移植物安全、等待名单死亡率和医疗资源)为 7 个国家计算了 QE 评分。QE 评分随时间的波动准确反映了大流行期间围绕移植活动的伦理紧张局势的动态变化。

结论

这种四分平衡的四维模型解决了当前大流行中的伦理紧张局势。它为指导在医疗系统负担不断增加的情况下对移植活动的监管提供了一个普遍适用的框架。

要点

在 COVID-19 大流行期间,需要制定伦理框架来平衡肝移植的需求与国家资源的可获得性。我们描述了一种四分平衡的四维模型,该模型可以模拟这些伦理紧张局势,并可以指导在医疗系统负担不断增加的情况下对移植活动的监管。

相似文献

1
An international multicenter study of protocols for liver transplantation during a pandemic: A case for quadripartite equipoise.国际性多中心研究方案在大流行期间进行肝脏移植:四方平衡的案例。
J Hepatol. 2020 Oct;73(4):873-881. doi: 10.1016/j.jhep.2020.05.023. Epub 2020 May 23.
2
Liver transplantation during the COVID-19 epidemic : recommendations from the Belgian Liver Intestine Transplant Committee (BeLIAC).2019冠状病毒病疫情期间的肝移植:比利时肝脏肠道移植委员会(BeLIAC)的建议
Acta Gastroenterol Belg. 2020 Apr-Jun;83(2):340-343.
3
Trinational Study Exploring the Early Impact of the COVID-19 Pandemic on Organ Donation and Liver Transplantation at National and Unit Levels.中澳新三国研究探索 COVID-19 大流行对国家和单位层面器官捐赠和肝移植的早期影响。
Transplantation. 2020 Nov;104(11):2234-2243. doi: 10.1097/TP.0000000000003416.
4
Lest we forget.切莫忘记。
Am J Transplant. 2020 Jul;20(7):1785-1786. doi: 10.1111/ajt.15888. Epub 2020 Jun 21.
5
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.肝移植受者感染 SARS-CoV-2 后的结局:一项国际注册研究。
Lancet Gastroenterol Hepatol. 2020 Nov;5(11):1008-1016. doi: 10.1016/S2468-1253(20)30271-5. Epub 2020 Aug 28.
6
Is It Time to Liberate Resources for Organ Transplantation Amid the COVID-19 Pandemic?在新冠疫情期间,是时候为器官移植释放资源了吗?
Prog Transplant. 2020 Sep;30(3):297-298. doi: 10.1177/1526924820933839. Epub 2020 Jun 15.
7
Ethical considerations regarding heart and lung transplantation and mechanical circulatory support during the COVID-19 pandemic: an ISHLT COVID-19 Task Force statement.COVID-19 大流行期间心肺移植和机械循环支持的伦理考量:ISHLT COVID-19 工作组声明。
J Heart Lung Transplant. 2020 Jul;39(7):619-626. doi: 10.1016/j.healun.2020.04.019. Epub 2020 Apr 25.
8
Ethical Issues in the COVID Era: Doing the Right Thing Depends on Location, Resources, and Disease Burden.新冠疫情时代的伦理问题:正确之举取决于地点、资源和疾病负担。
Transplantation. 2020 Jul;104(7):1316-1320. doi: 10.1097/TP.0000000000003291.
9
Allocation of liver grafts worldwide - Is there a best system?全球肝脏移植的分配 - 是否存在最佳系统?
J Hepatol. 2019 Oct;71(4):707-718. doi: 10.1016/j.jhep.2019.05.025. Epub 2019 Jun 12.
10
Use of SARS-CoV-2-infected deceased organ donors: Should we always "just say no?".使用感染 SARS-CoV-2 的已故器官捐献者:我们是否应该始终“说不”。
Am J Transplant. 2020 Jul;20(7):1787-1794. doi: 10.1111/ajt.16000. Epub 2020 Jun 11.

引用本文的文献

1
Inequities in mortality and potential years of life lost (PYLL) in greater Santiago, Chile, during and after the COVID-19 pandemic.智利大圣地亚哥在新冠疫情期间及之后的死亡率不平等和潜在寿命损失年数(PYLL)
Int J Equity Health. 2025 Jul 10;24(1):201. doi: 10.1186/s12939-025-02575-3.
2
Effects of Anti-COVID-19 Vaccination and Pre-Exposure Prophylaxis with Tixagevimab-Cilgavimab in Kidney and Liver Transplant Recipients.肾和肝移植受者中抗 COVID-19 疫苗接种和替沙格韦单抗-西加韦单抗预先暴露预防的效果。
Medicina (Kaunas). 2023 Nov 30;59(12):2101. doi: 10.3390/medicina59122101.
3
The positive impact of the COVID 19 pandemic on organ utilisation in liver transplantation.

本文引用的文献

1
Lest we forget.切莫忘记。
Am J Transplant. 2020 Jul;20(7):1785-1786. doi: 10.1111/ajt.15888. Epub 2020 Jun 21.
2
Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020.2020 年 2 月 12 日至 3 月 16 日,美国 2019 冠状病毒病(COVID-19)患者的严重结局。
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346. doi: 10.15585/mmwr.mm6912e2.
3
Critical Supply Shortages - The Need for Ventilators and Personal Protective Equipment during the Covid-19 Pandemic.
2019年冠状病毒病大流行对肝移植器官利用的积极影响。
J Liver Transpl. 2023 Feb;9:100131. doi: 10.1016/j.liver.2022.100131. Epub 2023 Jan 7.
4
Human Umbilical Cord Blood Mononuclear Cells Ameliorate CCl-Induced Acute Liver Injury in Mice Inhibiting Inflammatory Responses and Upregulating Peripheral Interleukin-22.人脐带血单个核细胞通过抑制炎症反应和上调外周白细胞介素-22改善小鼠四氯化碳诱导的急性肝损伤
Front Pharmacol. 2022 Jul 22;13:924464. doi: 10.3389/fphar.2022.924464. eCollection 2022.
5
Overview of Complications in Cirrhosis.肝硬化并发症概述
J Clin Exp Hepatol. 2022 Jul-Aug;12(4):1150-1174. doi: 10.1016/j.jceh.2022.04.021. Epub 2022 May 14.
6
Impact of COVID-19 on Liver Transplantation in Hong Kong and Singapore: A Modelling Study.2019年冠状病毒病对香港和新加坡肝移植的影响:一项建模研究。
Lancet Reg Health West Pac. 2021 Nov;16:100262. doi: 10.1016/j.lanwpc.2021.100262. Epub 2021 Sep 7.
7
Recent challenges facing patients with preexisting chronic liver disease in the era of the COVID-19 pandemic.新冠疫情时代慢性肝病患者面临的新挑战。
Ann Gastroenterol. 2021 Sep-Oct;34(5):625-633. doi: 10.20524/aog.2021.0628. Epub 2021 May 27.
8
COVID-19 and the liver: What do we know so far?新型冠状病毒肺炎与肝脏:我们目前了解到什么?
World J Hepatol. 2021 May 27;13(5):522-532. doi: 10.4254/wjh.v13.i5.522.
9
The Heterogenous Effect of COVID-19 on Liver Transplantation Activity and Waitlist Mortality in the United States.新冠病毒对美国肝移植活动及等待名单死亡率的异质性影响。
Front Surg. 2021 May 18;8:669129. doi: 10.3389/fsurg.2021.669129. eCollection 2021.
10
Liver Transplantation for T2 Hepatocellular Carcinoma during the COVID-19 Pandemic: A Novel Model Balancing Individual Benefit against Healthcare Resources.COVID-19大流行期间T2期肝细胞癌的肝移植:一种平衡个体获益与医疗资源的新模式
Cancers (Basel). 2021 Mar 19;13(6):1416. doi: 10.3390/cancers13061416.
关键物资短缺——新冠疫情期间对呼吸机和个人防护装备的需求
N Engl J Med. 2020 Apr 30;382(18):e41. doi: 10.1056/NEJMp2006141. Epub 2020 Mar 25.
4
Fair Allocation of Scarce Medical Resources in the Time of Covid-19.新冠疫情期间稀缺医疗资源的公平分配
N Engl J Med. 2020 May 21;382(21):2049-2055. doi: 10.1056/NEJMsb2005114. Epub 2020 Mar 23.
5
The Toughest Triage - Allocating Ventilators in a Pandemic.最艰难的分诊——在大流行中分配呼吸机
N Engl J Med. 2020 May 21;382(21):1973-1975. doi: 10.1056/NEJMp2005689. Epub 2020 Mar 23.
6
COVID-19: A global transplant perspective on successfully navigating a pandemic.COVID-19:从全球移植角度成功应对大流行。
Am J Transplant. 2020 Jul;20(7):1773-1779. doi: 10.1111/ajt.15876. Epub 2020 Apr 12.
7
Strategies to Inform Allocation of Stockpiled Ventilators to Healthcare Facilities During a Pandemic.在大流行期间为医疗机构分配库存呼吸机的策略。
Health Secur. 2020 Mar/Apr;18(2):69-74. doi: 10.1089/hs.2020.0028. Epub 2020 Mar 20.
8
Coronavirus disease 2019: Implications of emerging infections for transplantation.新型冠状病毒病 2019:新发感染对移植的影响。
Am J Transplant. 2020 Jul;20(7):1768-1772. doi: 10.1111/ajt.15832. Epub 2020 Mar 16.
9
COVID-19 in Singapore-Current Experience: Critical Global Issues That Require Attention and Action.新加坡的2019冠状病毒病——当前情况:需要关注和行动的重大全球问题
JAMA. 2020 Apr 7;323(13):1243-1244. doi: 10.1001/jama.2020.2467.
10
A Novel Coronavirus from Patients with Pneumonia in China, 2019.2019 年中国肺炎患者中的一种新型冠状病毒。
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.